Corporate Guide

Takara Bio Group

Contributing to the health of humanity through
the development of revolutionary biotechnology.

The Takara Bio Group aims to become a drug development company that promotes the development of the key technologies required to create biological drugs and continually creates new modalities (treatment methods) through its core businesses of Research Reagents and Scientific Instruments and CDMO Services* based on our corporate mission of contributing to the health of humanity through the development of revolutionary biotechnology.
  • *CDMO (Contract Development & Manufacturing Organization) support for regenerative medicine development
Sales by Business Category ¥78.1 billion
Reagents
84.3%
Instruments
1.8%
CDMO
10.5%
Gene Therapy
3.4%

*As of March 31, 2023

Takara Bio Group News

View All